Search Results
Search for other papers by Adile Begüm Bahçecioğlu in
Google Scholar
PubMed
Search for other papers by Alptekin Gürsoy in
Google Scholar
PubMed
Search for other papers by Serpil Dizbay Sak in
Google Scholar
PubMed
Search for other papers by Seyfettin Ilgan in
Google Scholar
PubMed
Search for other papers by Banu Bilezikçi in
Google Scholar
PubMed
Search for other papers by Murat Faik Erdoğan in
Google Scholar
PubMed
Introduction Ultrasonographic (US) echogenic microfoci (EMF) are frequently seen in papillary thyroid carcinoma (PTC). European Thyroid Association, the American College of Radiology (ACR), and the Korean Society of Thyroid Radiology classify
Search for other papers by Sang-Hyeon Ju in
Google Scholar
PubMed
Search for other papers by Yong Bae Ji in
Google Scholar
PubMed
Search for other papers by Minchul Song in
Google Scholar
PubMed
Search for other papers by Joung Youl Lim in
Google Scholar
PubMed
Search for other papers by Da Beom Heo in
Google Scholar
PubMed
Search for other papers by Min-Gyu Kim in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Search for other papers by Jae Won Chang in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea
Search for other papers by Ho-Ryun Won in
Google Scholar
PubMed
Search for other papers by Yea Eun Kang in
Google Scholar
PubMed
Search for other papers by Eu Jeong Ku in
Google Scholar
PubMed
Search for other papers by Mijin Kim in
Google Scholar
PubMed
Search for other papers by Eun Kyung Lee in
Google Scholar
PubMed
Search for other papers by June Young Choi in
Google Scholar
PubMed
Search for other papers by Hyeong Won Yu in
Google Scholar
PubMed
Search for other papers by Young Joo Park in
Google Scholar
PubMed
Search for other papers by Jun-Ho Choe in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
Search for other papers by the MASTER study group † in
Google Scholar
PubMed
.6–4.8% between 2003 and 2019 ( 4 ). Consequently, given the resulting prevalence of low-risk papillary thyroid carcinoma (PTC) patients and the burden posed by the potential complications, active surveillance (AS) has received increased attention ( 6 , 7
Search for other papers by Kaoru Kobayashi in
Google Scholar
PubMed
Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Search for other papers by Tomonori Yabuta in
Google Scholar
PubMed
Search for other papers by Mitsuhiro Fukushima in
Google Scholar
PubMed
Search for other papers by Minoru Kihara in
Google Scholar
PubMed
Search for other papers by Yuuki Takamura in
Google Scholar
PubMed
Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Search for other papers by Akihiro Miya in
Google Scholar
PubMed
Search for other papers by Nobuyuki Amino in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
patients with honeycomb-like papillary thyroid carcinoma showing multiple small cysts, and describe the characteristic features on ultrasonography. Methods and Patients Ultrasonographic examination was performed by well-trained registered
Search for other papers by Daniela Cavaco in
Google Scholar
PubMed
Search for other papers by Ana Filipa Martins in
Google Scholar
PubMed
Search for other papers by Rafael Cabrera in
Google Scholar
PubMed
Search for other papers by Helena Vilar in
Google Scholar
PubMed
Nova Medical School, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC) is the most common thyroid cancer, accounting for more than 85% of the thyroid malignant lesions ( 1 ). An increase of its prevalence is recognized worldwide, mainly due to overdiagnosis of
Otorhinolaryngology, Tan Tock Seng Hospital, Singapore, Singapore
Search for other papers by Hao Li in
Google Scholar
PubMed
Otolaryngology, Head and Neck Surgery, Sheba Medical Center, Ramat Gan, Israel
Search for other papers by Nir Livneh in
Google Scholar
PubMed
Search for other papers by Snjezana Dogan in
Google Scholar
PubMed
Search for other papers by Ashok R. Shaha in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC) are thyroid neoplasms derived from different cell types. While the former is common, the latter is much less frequent [ 1 , 2 ]. The synchronous occurrence
Search for other papers by Ian D Hay in
Google Scholar
PubMed
Search for other papers by Suneetha Kaggal in
Google Scholar
PubMed
Search for other papers by Geoffrey B Thompson in
Google Scholar
PubMed
Introduction Adults with low-risk ( 1 ) papillary thyroid carcinoma (PTC) represent the commonest endocrine malignancy ( 2 ). In 2017, Pontius and colleagues ( 3 ) demonstrated, in a study of 244,040 PTC patients managed in USA during 2004
Search for other papers by Pedro Marques in
Google Scholar
PubMed
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Maria João Bugalho in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy. The widespread use of neck ultrasound (US) has led to the identification of small asymptomatic thyroid nodules with indeterminate clinical relevance [ 1
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
Search for other papers by Sule Canberk in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Joana C. Ferreira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Luísa Pereira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Rui Batısta in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Andre F. Vieira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
Department of Pathology and Oncology, Centro Hospitalar São João, Porto, Portugal
Search for other papers by Manuel Sobrinho Simões in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Valdemar Máximo in
Google Scholar
PubMed
well-established driver mutations [ 1 , 2 ]. Papillary thyroid carcinoma (PTC), the most common type (i.e., 90% of all thyroid malignancies) probably contributes to most such tumours in this “dark zone” [ 3 ]. Approximately 90% of thyroid cancers
Search for other papers by Shinsuke Shinkai in
Google Scholar
PubMed
Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kenji Ohba in
Google Scholar
PubMed
Search for other papers by Kennichi Kakudo in
Google Scholar
PubMed
Search for other papers by Takayuki Iwaki in
Google Scholar
PubMed
Search for other papers by Yoshihiro Mimura in
Google Scholar
PubMed
Search for other papers by Akio Matsushita in
Google Scholar
PubMed
Search for other papers by Go Kuroda in
Google Scholar
PubMed
Search for other papers by Yuki Sakai in
Google Scholar
PubMed
Search for other papers by Nobuhiko Nishino in
Google Scholar
PubMed
Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kazuo Umemura in
Google Scholar
PubMed
Search for other papers by Takafumi Suda in
Google Scholar
PubMed
Search for other papers by Shigekazu Sasaki in
Google Scholar
PubMed
common somatic mutation in papillary thyroid carcinoma). What Does This Case Report Add? • We identified concurrent BRAF mutation and TSHR polymorphism for the first time in a case of hyperfunctioning malignant thyroid nodule. • The findings
Search for other papers by Pedro Weslley Souza Rosario in
Google Scholar
PubMed
Search for other papers by Gabriela Franco Mourão in
Google Scholar
PubMed
Search for other papers by Pedro Henrique Lopes Oliveira in
Google Scholar
PubMed
Search for other papers by Tulio Henrique Silva in
Google Scholar
PubMed
Introduction Patients with small papillary thyroid carcinomas (PTC) can currently be maintained under active surveillance (AS) instead of being submitted to immediate surgery [ 1 - 5 ]. This management is accepted for cases in which the risk